Revista de la Facultad de Medicina Humana
Volume 21

Issue 2

Article 4

2021

Variants in COVID: Research Opportunity.
Félix Llanos-Tejada
Hospital Nacional Dos de Mayo, Lima-Perú., felex3d@yahoo.com

Follow this and additional works at: https://inicib.urp.edu.pe/rfmh

Recommended Citation
Llanos-Tejada, Félix (2021) "Variants in COVID: Research Opportunity.," Revista de la Facultad de Medicina
Humana: Vol. 21: Iss. 2, Article 4.
DOI: https://doi.org/10.25176/RFMH.v21i2.3743
Available at: https://inicib.urp.edu.pe/rfmh/vol21/iss2/4

This Editorial is brought to you for free and open access by INICIB-URP. It has been accepted for inclusion in
Revista de la Facultad de Medicina Humana by an authorized editor of INICIB-URP.

Llanos-Tejada: Variants in COVID: Research Opportunity.ISSN Versión Online: 2308-0531

Rev. Fac. Med. Hum. April 2021;21(2):257-258.

Facultad de Medicina Humana URP

DOI 10.25176/RFMH.v21i2.3743
EDITORIAL

COVID-19 VARIANTS: RESEARCH OPPORTUNITY
VARIANTES EN COVID: OPORTUNIDAD DE INVESTIGACIÓN
Félix Llanos-Tejada1,a, Renzo Villanueva-Villegas1,b

At a time of social distancing, we must show greater unity than ever before.
This is an unprecedented reality that will inevitably lead us to change the way we behave as social beings.
Therefore, we need reliable information from properly designed and conducted studies. This information
will help us understand what we are currently suffering from and therefore respond to the circumstances
and scientific evidence. It is therefore vital to recognize the importance of basic and applied research in
the context of today's health emergency in our environment and around the world.

EDITORIAL

In this respect, Peruvian universities, both public and private, have an important role to play as institutions
that welcome and prioritize research. In addition to the challenge of new teaching practices, that is the
transition from unidirectional (face-to-face) to reciprocal (remote) teaching, where the teacher will be
the guide in the student's learning(1), the university shall promote, encourage and enhance the training
of researchers and cooperation with research groups of international institutions.
Likewise, the State and private enterprises must support these academic institutions, by investing in
science which will generate the necessary knowledge that will serve as the basis for producing the
technology that should foster the development of the country.
Therefore, universities should propose development and research plans, regardless of which protocols
may be proposed or managed by the World Health Organization (WHO)(2). Thus, in this second wave, it
is vitally important to reassess and categorize the new risk factors for the evolution of the severity of
COVID-19, as well as studies to determine the presence of variants in our environment.
Michael Osterholm, Director of the Center for Infectious Disease Research and Policy at the University of
Minnesota, in an interview on NBC's Meet the Press show, said the COVID-19 pandemic is about to get
unprecedentedly worse, and, referring to the increase in cases associated with the new variants of the
coronavirus, predicted that "hurricane is coming", labeled "COVID-19 Hurricane", an expression intended
to consolidate the elements that may lead to a new clinical presentation of the pandemic(4). During the
interview, Dr. Osterholm indicated that in our environment, the following variations are thought to be
circulating: B.1.1.7 from the UK (which increases transmission, with little evidence of immune evasion,
which increases ~50% transmission and ~30% lethality), B.1.351 from South Africa (with little evidence
of increased transmission and presence of immune evasion) and P.1 from Brazil (same as above, with
little evidence of increased transmission and presence of immune evasion)(3). Therefore, the vaccine's
response to these new forms of coronavirus is a concern, and this is becoming a trend in terms of what
the future holds.
During the "first wave" of SARS-CoV-2 infection in our country, seroprevalence frequencies ranged from
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38.8% in the city of Cuzco(5) to 70% in the city of
Iquitos(6). During this "second wave", according to
the Health Organization (WHO), there has been an
increase in new cases and lethality since the 52nd
epidemiological week of the year 2020, to this
day(7) in our country. This second wave gives us the
possibility to assess and study the evolution of the
clinical picture (which appears to be more complex),
the severity and fatality of the illness (which appears
to be higher), the search for new associated risk
factors (which appears to be in younger patients,
with onset of chronic non-communicable diseases
and females), the risk of self-medication (which
appears more severe because of the irrational use
of broad-spectrum antibiotics) and the effect on
health personnel, who are exhausted and have high
rates of affective disorders, such as anxiety, reactive
depression and post-traumatic stress. In this context,
it is also important to promote studies that seek
to identify genetic variants linked to the results of
COVID-19. These genetic variants can be evaluated
not just in the SARS-CoV-2 virus, but also in the host,
so the findings would be useful in determining the
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risk for severe forms of COVID-19 in some affected
individuals. A recent study in the United Kingdom(8)
suggests that this variant is more infectious and with
an increased risk of mortality. And, considering that
the variants are similar, it is likely that they behave
the same, explaining the changes in clinical behavior.
As a result, the response to COVID-19 Hurricane
will require quicker vaccine delivery and improved
genomic monitoring. It will also require transmission
reduction strategies that have been recommended
since the beginning of the pandemic, such as the
use of properly worn masks, adherence to physical
distancing, and limiting time indoors between
people not living under the same roof.
Finally, another consideration for research in this
emerging COVID-19 context is the impetus of studies
on COVID-19 syndrome(9) to try to understand and
deal with what this pandemic is generating in those
affected and in society. As well as the effects in the
psycho-affective sphere of the users, external and
internal, of the health institutions.
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